Acorda Therapeutics Inc (NASDAQ:ACOR)

35.01
Delayed Data
As of Mar 02
 +1.17 / +3.46%
Today’s Change
28.26
Today|||52-Week Range
45.45
-14.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues80.5M97.1M106.0M117.9M
 
 
 
 
 
Cost of Goods Sold13.9M17.2M19.0M25.1M
 
 
 
 
 
Depreciation And Amortization1.8M1.9M1.8M--
 
 
 
 
 
Operating ExpensesGross Income64.8M78.1M85.2M92.7M
 
 
 
 
 
General Expenses61.4M67.1M62.2M82.4M
 
 
 
 
 
Research And Development14.5M16.4M16.6M25.9M
 
 
 
 
 
Total Operating Expenses77.1M86.1M82.9M107.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.4M11.0M23.1M10.4M
 
 
 
 
 
Extraordinary Charge-29.0K-9.0K-2.4M-9.2M
 
 
 
 
 
Interest Expense On Debt92.0K426.0K4.6M--
 
 
 
 
Other Expenses0.000.00167.0K-3.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.5M10.7M16.5M-2.7M
 
 
 
 
 
Income Taxes-2.8M-6.0M-4.5M-3.0M
 
 
 
 
 
Net Income703.0K4.7M12.0M331.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.9M41.0M41.1M41.5M
 
 
 
 
 
Shares To Calculate EPS Diluted42.2M42.4M42.4M43.1M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02$0.11$0.28$0.01
 
 
 
 
 
EPS Diluted$0.02$0.11$0.28$0.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account